RT Journal Article
SR Electronic
T1 Expression profile analysis of COVID-19 patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.12.03.23299339
DO 10.1101/2023.12.03.23299339
A1 Shimansky, Valentin S.
A1 Popov, Oleg S.
A1 Klochkova, Tatiana G.
A1 Apalko, Svetlana V.
A1 Sushentseva, Natalya N.
A1 Anisenkova, Anna Yu.
A1 Mosenko, Sergey V.
A1 Shcherbak, Sergey G.
YR 2023
UL http://medrxiv.org/content/early/2023/12/08/2023.12.03.23299339.abstract
AB The course of COVID-19 is determined by various factors. Studies worldwide have shown a correlation between changes in the expression profile and the severity of the disease. Thus, an in-depth study of differentially expressed genes will allow a more detailed investigation of the metabolic changes occurring in the background of coronavirus infection. The technique of RNA sequencing and subsequent bioinformatics analysis is suitable for such research tasks. In our study, we compared groups of samples from patients with mild and severe disease course and identified a number of differentially expressed genes. These genes are involved in metabolic pathways responsible for immune response, signaling, intercellular communication, metabolism of various compounds etc. We then identified master regulators whose function and role in pathways enriched by differentially expressed genes makes them potential targets for biochemical and meta-studies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementSupported by Saint Petersburg State University, project ID: 94029859Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the expert ethics board of the St. Petersburg State Health Care Institution "City Hospital No. 40" (protocol No. 171 dated May 18, 2020).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.